Why the 2023 VMware ELA playbook does not protect you against the 2026 portfolio bundle.

The 2023 VMware Enterprise License Agreement was a known instrument. The agreement covered VMware products across a single line, with a pre negotiated discount band, a published renewal escalator, and a true up procedure the procurement team understood. Buyers who held a 2023 ELA approached the 2026 renewal expecting to reuse the playbook the ELA had built. The Desk has now reviewed eleven renewals against expiring 2023 ELAs, and the pattern is clear enough to file as a position note. The 2023 ELA playbook does not protect the buyer against the 2026 portfolio bundle. The agreement structure that the ELA assumed no longer exists. The buyer who walks in expecting an ELA renewal walks out with a portfolio subscription priced on terms the ELA was never written to govern.

The portfolio bundle is the new construct. It replaces the line item ELA with a bundled subscription at the VCF level, plus separately priced bundles at the Symantec, Carbon Black, and CA practice areas. The bundles are not negotiated independently. They are sequenced by the seller's portfolio manager, with the VCF renewal often used as the anchor for cross practice movement. The 2023 ELA playbook treated VMware as a single contract. The 2026 bundle treats the buyer's full Broadcom estate as one negotiation. The shift is the central fact of the renewal cycle, and it changes most of what the ELA holder needs to do.

This piece runs through the five places the 2023 ELA playbook fails against the 2026 bundle and what the buyer needs to do instead. The five places are: the renewal anchor, the discount calculation, the true up mechanic, the cross product trade, and the escalator clause. Each one carried a clean instrument in the ELA. Each one now sits inside a portfolio mechanic the ELA did not anticipate.

Failure one: the renewal anchor

The 2023 ELA priced the renewal against the prior contract value. The escalator clause governed the year over year movement, and the anchor was the prior period revenue. The buyer's procurement team validated the anchor against the prior contract and the conversation moved on. The 2026 portfolio bundle does not anchor on the prior ELA. The bundle anchor is the central published rate at the portfolio level, with discount bands derived from the buyer's total estate value across all Broadcom practices. The prior ELA is a reference document, not an anchor.

The buyer who arrives with the prior ELA as the negotiation anchor is asking the seller to price against an instrument the seller has retired. The replacement play is the cross practice rate sheet. The buyer produces a portfolio level view of the central published rates against the buyer's full Broadcom footprint, with the discount band the buyer is eligible for at the portfolio level. The artefact is harder to assemble than the prior ELA but produces a credible anchor against the 2026 mechanic. The Desk has seen the artefact produce a 6 to 13 percent reduction against the seller's opening portfolio quote, before any product level negotiation begins.

Failure two: the discount calculation

The 2023 ELA carried a pre negotiated discount band that applied across all products in the ELA. The discount was a single number. The buyer applied it against any line in the contract and the calculation worked. The 2026 portfolio bundle does not carry a single discount. The discount band varies by practice area, by product within the practice, and by the buyer's documented usage of each product. The single number from the 2023 ELA does not survive the disaggregation.

The replacement play is the practice level discount review. The buyer holds the seller to publishing the discount band for each practice in the portfolio and the discount band for each product inside each practice. The published bands become the anchor against which the line by line negotiation runs. The disaggregation is more procedurally heavy than the 2023 ELA, but it surfaces variances the single discount obscured. The Desk has seen variances of 4 to 18 percent across practices on the same portfolio quote.

"The ELA was a clean instrument that priced a known product set against a known discount. The portfolio bundle prices an estate against itself. The grammar is different. The buyer needs to learn it before the close, not after."Engagement Lead, The Desk

Failure three: the true up mechanic

The 2023 ELA carried a true up clause that allowed the buyer to grow consumption through the term and settle the variance at renewal. The clause was a known instrument. The buyer's operations team grew into the entitlement and the procurement team settled the variance against the published unit rate at renewal time. The 2026 portfolio bundle does not carry a single true up at the portfolio level. The true up sits inside each practice bundle and runs against a different unit in each. VCF true ups run against the core count. Symantec true ups run against the seat count. Carbon Black true ups run against the agent count. CA true ups run against the API call volume or the AIOps managed object count. The buyer who treats the portfolio true up as a single conversation is missing four to seven separate true up mechanics that are running in parallel.

The replacement play is the practice level true up calendar. The buyer maps the true up date and the true up unit for each practice in the portfolio and runs each true up as a separate negotiation. The Desk has seen buyers leave between $400,000 and $2.1M on the table by treating the portfolio true up as a single conversation. The variance is consistent enough across the cohort to publish as a working figure.

Failure four: the cross product trade

The 2023 ELA allowed cross product trades inside the contract. The buyer could trade entitlement on one VMware product for entitlement on another, with the seller's account team validating the trade against the prior contract. The trade was an internal instrument that did not require central approval. The 2026 portfolio bundle does not carry a cross product trade authority at the practice level. The deal desk inside each practice can adjust entitlements inside the practice, but cross practice trades require portfolio level approval and the approval cycle runs longer than the renewal window.

The replacement play is the cross practice trade requested in writing at the portfolio level, with a 60 day lead time before the renewal close. The trade is procedurally available but slower than the ELA trade. The buyer who asks for the trade three weeks before close will not see it land. The buyer who asks 60 days out will. The Desk has seen the trade produce reductions of 7 to 15 percent on the practice receiving the entitlement, against the published rate, when the trade is requested with proper lead time.

Failure five: the escalator clause

The 2023 ELA included an escalator clause that capped the year over year increase across the contract. The clause was a single number. The buyer applied it against any line in the renewal. The 2026 portfolio bundle does not carry a single escalator. Each practice bundle carries its own escalator, with the VCF subscription typically carrying the highest band and the CA practice typically carrying the lowest. The buyer who applies the 2023 single escalator against the 2026 portfolio is reading the wrong document.

The replacement play is the practice level escalator review with a written request for the buyer's preferred escalator inside each practice. The seller will not flatten the escalator across the portfolio. The seller will adjust the escalator inside each practice against the buyer's commitment posture. The buyer who asks for a flat 3 percent escalator across the portfolio will not see it. The buyer who asks for a flat 3 percent inside the CA practice, a flat 4 percent inside Carbon Black, and a flat 5 percent inside VCF will see two of those three land. The escalator review is the smallest line of value in the failure list but it compounds across the term.

The pattern under the five failures

The five failures share a common shape. The 2023 ELA was a single instrument that governed a single product set. The 2026 portfolio bundle is five to seven instruments that govern an estate. The 2023 playbook treats the renewal as one conversation. The 2026 reality is a portfolio sequence. The buyer who runs the 2023 ELA playbook against the 2026 portfolio bundle leaves value on the table at each of the five failure points, and the total across the renewal sits in the band of 18 to 31 percent of the opening portfolio quote.

What we have seen on live deals

A regional bank in EMEA brought an expiring 2023 ELA to the Desk in February 2026, with a procurement team that expected a renewal conversation inside the prior ELA framework. The seller arrived with a portfolio bundle covering VCF, Symantec endpoint, and CA AIOps. The bank's first round followed the ELA playbook. The seller's response was a procedural acknowledgment and a small concession on the VCF line. The Desk rebuilt the approach around the five replacement plays. Cross practice rate sheet. Practice level discount review. Practice level true up calendar. Cross practice trade requested with 60 day lead time. Practice level escalator review. The second round closed the portfolio renewal at 26 percent below the seller's opening quote.

A Fortune 200 manufacturer brought an expiring ELA with a smaller footprint, $11M annual run rate. The replacement playbook produced a $2.8M annual reduction across the new portfolio term. The 2023 ELA playbook unchanged would have produced a reduction of roughly $500,000. The differential is the cost of treating the 2026 portfolio bundle as a 2023 ELA.

The takeaway

• The 2023 ELA priced a known product set against a single discount, a single escalator, and a single true up. The 2026 portfolio bundle prices an estate against itself, with separate discounts, escalators, and true ups inside each practice.
• The 2023 ELA playbook fails at five identifiable points against the 2026 bundle: the renewal anchor, the discount calculation, the true up mechanic, the cross product trade, and the escalator clause. Each failure carries a measurable cost.
• Across eleven renewals the buyer who runs the 2023 ELA playbook unchanged leaves 18 to 31 percent of the opening portfolio quote on the table. The replacement playbook needs to be in hand before the renewal conversation opens, not built during it.